TRANSIL-HSA High-Throughput assay 384 well plate
NIMBUS Biotechnology GmbH384 well plate for the determination of protein binding on HSAconfiguration: 93 compounds1 reference/ 3 TRANSIL® - HSA concentrations per compound
NIMBUS Biotechnology GmbH Products & Reviews
25
NIMBUS Biotechnology is a leading provider of high-throughput assays, based on the well-known proprietary TRANSIL® technology for assessing ADME related parameters and for the prediction of ADME behaviour right from the start of the project. The NIMBUS TRANSIL® platform is a patented bead based assay technology allowing for the biofunctionalization of solid supports and enabling the company to develop innovative cutting-edge assays for drug discovery processes. Our unique ADME profiling service, NIMBUS Screening (in vitro and in silico), supports selection decisions at all stages.